Effects of Static Stretching Versus Post Facilitation Stretch of Iliopsoas in Non-Specific Low Back Pain

This study is a randomized controlled trial and the purpose of this study is to determine the effects of Static Stretching Versus Post Facilitation Stretch of Iliopsoas combined with core stability exercises in Non-Specific Low Back Pain"

Study Overview

• Status: Recruiting
• Conditions: Low Back Pain
• Intervention / Treatment: Procedure: Core stability exercises; Procedure: Static Stretching of Iliopsoas; Procedure: Post Facilitation Stretch of Iliopsoas

Detailed Description

The purpose of this study is to determine the effects of Static Stretching Versus Post Facilitation Stretch of Iliopsoas on Pain, physical function, lumbar ROM and Hip ROM in patients Non-Specific Low Back Pain" adults (age : 30-50 years )

1. Numeric pain rating scale
2. Goniometer
3. Inclinometer
4. Oswestry Disability Questionairre Data will be collected before and after the intervention protocol for each participant.

Data collection procedure: Participants of interest would be approached and explained about the research. Informed written consent will be taken. Pre and post intervention scores will be recorded.

• Study Type: Interventional
• Enrollment (Estimated): 40
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Muhammad Mateen, MS-MSKPT*; Phone Number: 03335030624; Email: mateenayaz148@gmail.com

Study Locations

• Pakistan
  • Punjab
    • Rawalpindi, Punjab, Pakistan, 46000
      • Recruiting
      • Foundation University College of Physical Therapy
      • Contact: Sana Khalid, MSNMPT,PHD; Phone Number: 03315050460; Email: sana.khalid@fui.edu.pk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria

• Gender: Both male and female
• Individuals aged 30-50 years
• Non-Specific low back pain for at least 3 months
• pain radiating no further than the buttock
• Pain range between 3-8 on NPRS
• Positive Thomas Test

Exclusion Criteria:

• Diagnosis of systemic metabolic and/or neurological disorder, neuromuscular disorders, pregnancy
• Patients who have been receiving any other physical therapy treatment for NSLBP in the same period of the interventions
• Patients having Low back pain with any specific cause

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Static Stretching Group; Core stabilization exercises along with Static Stretching of Iliopsoas (Hold for 7-8s x 10 reps) Week 1 Lifting the leg while lying in a prone position with the knee bent Week 2 Lifting the leg in a prone position with a straight knee Week 3 Stretch in the modified Thomas test position Week 4 Modified launch stretch	Procedure: Core stability exercises; Core stability Exercises will include: PLANK SIDE PLANK BIRD DOG MS GILL CURLUP PLANK + LEG RAISES SIDE PLANK + LEG RAISES PLANK + WALKS SIDE TO SIDE SIDE PLANK + TWIST BIRD DOG; Procedure: Static Stretching of Iliopsoas; Static Stretching of Iliopsoas (Hold for 7-8s x 10 reps) Week 1 Lifting the leg while lying in a prone position with the knee bent Week 2 Lifting the leg in a prone position with a straight knee Week 3 Stretch in the modified Thomas test position Week 4 Modified launch stretch
Experimental: PFS Group; Core stabilization exercises along with Post Facilitation Stretch of Iliopsoas (5-10s x 10 reps) Patient's position supine at the edge of the table, non-effected hip and knee in flexion, experimental thigh and leg hang on the edge of table. Extend the hip of the opposite thigh up to the barrier. After that, the patient flexes the hip against maximal resistance (isometric) and breathes in for 5-10 seconds. Tell the patient "Relax", whereas the therapist applies a rapid stretch to a new barrier and is held for 10 seconds.	Procedure: Core stability exercises; Core stability Exercises will include: PLANK SIDE PLANK BIRD DOG MS GILL CURLUP PLANK + LEG RAISES SIDE PLANK + LEG RAISES PLANK + WALKS SIDE TO SIDE SIDE PLANK + TWIST BIRD DOG; Procedure: Post Facilitation Stretch of Iliopsoas; Post Facilitation Stretch of Iliopsoas (5-10s x 10 reps) Patient's position supine at the edge of the table, non-effected hip and knee in flexion, experimental thigh and leg hang on the edge of table. Extend the hip of the opposite thigh up to the barrier. After that, the patient flexes the hip against maximal resistance (isometric) and breathes in for 5-10 seconds. Tell the patient "Relax", whereas the therapist applies a rapid stretch to a new barrier and is held for 10 seconds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain intensity	It will be measured using Numeric Pain Rating Scale.It has a scale of 0-10 or 0-100 points and can be given verbally or in writing.	4 weeks
Level of disability	It will be measured using Oswestry disability Index Questionairre	4 weeks
Lumbar Range of motion	Lumbar ROM will be measured using Inclinometer	4 weeks
Hip Range of motion	Hip ROM will be measured using Goniometer	4 Weeks

Collaborators and Investigators

• Sponsor: Foundation University Islamabad

Study record dates

Study Major Dates

• Study Start (Actual): July 15, 2023
• Primary Completion (Actual): November 20, 2023
• Study Completion (Estimated): June 20, 2024

Study Registration Dates

• First Submitted: April 23, 2024
• First Submitted That Met QC Criteria: April 23, 2024
• First Posted (Actual): April 29, 2024

Study Record Updates

• Last Update Posted (Actual): April 29, 2024
• Last Update Submitted That Met QC Criteria: April 23, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain; Low Back Pain
• Other Study ID Numbers: FUI/CTR/2024/5

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No